You need an actual evaluation BMI calculation, review of weight-related conditions, medication history, and screening for contraindications
That framing matters because it changes the question from chemistry to tolerability and monitoring
This is a general pharmacokinetic principle based on the protein stability characteristics of each formulation
Baseline Screening: Mandatory blood panels within 30 days of starting treatment
Legitimate prescribing facilities need doctors to send in the prescription, and a doctor can't do that without seeing your blood test results to check for things like diabetes or markers that could make you ineligible for something like a GLP-1 prescription
Finally, when compared with placebo, SGLT-2 inhibitors are associated with a robust reduction of hospitalization for HHF and renal outcome, and a moderate reduction of CV and total death, and MACE [13]